Advance and unmet need of health care for patients with rheumatoid arthritis in the German population - Results from the German Rheumatoid Arthritis Population Survey (GRAPS)

Rheumatology

Volumn 48, Issue 6, 2009, Pages 650-657

  Westhoff, Gisela ^a   Schneider, Matthias ^b   Raspe, Heiner ^c   Zeidler, Henning ^d   Runge, Claus ^e   Volmer, Timm ^e   Zink, Angela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Rheumatologikum Hannover   (Germany)

^e Wyeth Pharma GmbH   (Germany)

Author keywords

DMARD; Drug therapy; Germany; Population survey; Quality of health care; RA; RF

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONSULTATION; CONTROLLED STUDY; DRUG USE; FUNCTIONAL TRAINING; GERMANY; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; JOINT SURGERY; MAJOR CLINICAL STUDY; NEEDS ASSESSMENT; PATIENT CARE; PHYSIOTHERAPY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GERMANY; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RHEUMATOLOGY;

EID: 65849258869     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep045     Document Type: Article

References (44)

1. Pincus T. Long-term outcome in rheumatoid arthritis. Br J Rheumatol 1995; 34(Suppl. 2):59-73.
2. Gonzalez A, Maradit KH, Crowson CS et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583-7.
3. MacGregor AJ, Bamber S, Silman AJ. A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol 1994;21:1420-6.
4. Helmick CG, Felson DT, Lawrence RC et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum 2008;58(1):15-25.
5. Symmons D, Turner G, Webb R et al. The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology 2002;41:793-800.
6. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. Comparison of treatment strategies in early rheumatoid arthritis: A randomized trial. Ann Intern Med 2007;146:406-15.
7. Puolakka K, Kautiainen H, Mottonen T et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial. Arthritis Rheum 2004;50:55-62.
8. Verstappen SM, Jacobs JW, Bijlsma JW et al. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003;48:1797-807.
9. van der Heijde D. Long-term effects of early treatment in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2007;3:258-9.
10. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328-46.
11. Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum 2001;44:1504-14.
12. Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
13. Fransen J, Stucki G, Twisk J et al. Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: A controlled clinical trial. Ann Rheum Dis 2003;62:624-9.
14. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
15. Van Der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK et al Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. Advance Access published July 28, 2008, doi: 0: ard.2008.092254v1.
16. Zeidler H, Merkesdal S, Hulsemann JL. Early arthritis and rheumatoid arthritis in Germany. Clin Exp Rheumatol 2003;21(5 Suppl 31):S106S112.
17. Emery P, Breedveld FC, Lemmel EM et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000;39:655-5.
18. Mau W, Wasmus A, Raspe HH. Epidemiologie und versorgung der rheumatoiden arthritis (RA) im Stadtgebiet von Hannover. München: GSF (Abschlußbericht), 1991.
19. Wasmus A, Kindel P, Mattussek S, Raspe HH. Activity and severity of rheumatoid arthritis in Hanover/FRG and in one regional referral center. Scand J Rheumatol 1989;79(Suppl.):33-44.
20. Wasmus A, Kindel P, Raspe HH. Epidemiologie der Behandlung bei an chronischer Polyarthritis Erkrankten in Hannover [Epidemiology of treatment of rheumatoid arthritis in Hanover]. Z Rheumatol 1991;18:334-8.
21. Zink A, Huscher D, Thiele K, Listing J, Schneider M. [National database of German arthritis centers. Tool for health services research]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004;47:526-32.
22. Potthoff P, Heinemann L, Güther B. A household panel as a tool for cost-effective health-related population surveys: Validity of the 'Healthcare Access Panel'. German Medical Science 2005;2:16-24.
23. Raspe HH, Hagedorn U, Kohlmann T, Mattussek S. Der Funktionsfragebogen Hannover (FFbH): Ein Instrument zur Funktionsdiagnostik bei polyartikulären gelenkerkrankungen. In: Siegrist J, ed. Wohnortnahe Betreuung Rheumakranker. Ergebnisse sozialwissenschaftlicher Evaluation eines Modellversuchs. Stuttgart: Schattauer, 1990;164-82.
24. Lunt M, Symmons DP, Silman AJ. An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis: Performance over five years in a primary care-based prospective study. Arthritis Rheum 2005;52:2277-83.
25. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
26. Lawrence RC, Felson DT, Helmick CG et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 2008;58:26-35.
27. Van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: Results of a followup study. J Rheumatol 1993;20(8):1288-1296.
28. Knijff-Dutmer E, Drossaers-Bakker W, Verhoeven A et al. Rheumatoid factor measured by fluoroimmunoassay: A responsive measure of rheumatoid arthritis disease activity that is associated with joint damage. Ann Rheum Dis 2002;61:603-7.
29. Houssien DA, Jonsson T, Davies E, Scott DL. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: Comparative effects of different antigens. Scand J Rheumatol 1998;27:46-53.
30. Mottonen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with 'sawtooth" strategy. Ann Rheum Dis 1998;57:533-9.
31. Raspe HH, Mau W, Wasmus A. Treatment profiles in different groups of RA-sufferers: Description, analysis, evaluation. Scand J Rheumatol 1989;79(Suppl.):57-65.
32. Cimmino MA, Hazes JM. Introduction: Value of epidemiological research for clinical practice. Best Pract Res Clin Rheumatol 2002;16(5):vIi-xii.
33. Andrianakos A, Trontzas P, Christoyannis F et al. Prevalence and management of rheumatoid arthritis in the general population of Greece-the ESORDIG study. Rheumatology 2006;45:1549-54.
34. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98.
35. Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R, Laffon A. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology 2002;41:88-95.
36. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003;48:917-926.
37. Laiho K, Tuomilehto J, Tilvis R. Prevalence of rheumatoid arthritis and musculoskeletal diseases in the elderly population. Rheumatol Int 2001;20:85-87.
38. Kitamura CR, Rohekar G, Bykerk VP, Carette S. Are the 2002 American College of Rheumatology guidelines for the management of rheumatoid arthritis being followed in Canada's largest academic rheumatology center? J Rheumatol 2007;34:2183-92.
39. Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: A population study. Arthritis Rheum 2005;53:241-8.
40. Maclean CH, Louie R, Leake B et al. Quality of care for patients with rheumatoid arthritis. J Am Med Assoc 2000;284:984-92.
41. Zink A, Listing J, Niewerth M, Zeidler H, for the German Collaborative Arthritis Centres. The National Database of the German Collaborative Arthritis Centres - treatment of patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:207-13.
42. Zink A, Listing J, Ziemer S, Zeidler H. for the German Collaborative Arthritis Centres. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 2001;28:2201-8.
43. Saunders SA, Capell HA, Stirling A et al. Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum 2008;58:1310-7.
44. Kommission Versorgung der Deutschen Gesellschaft für Rheumatologie. Memorandum rheumatologische Versorgung von akut und chronisch Rheumakranken in Deutschland. 2008.